Research programme: antibody-drug conjugates - Eli Lilly/ImmunoGenAlternative Names: Lilly 1
Latest Information Update: 02 Dec 2013
At a glance
- Originator Eli Lilly; ImmunoGen
- Class Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 25 Nov 2013 Preclinical trials in Cancer in USA (Parenteral)
- 21 Dec 2011 Early research in Cancer in USA (Parenteral)